Vectatone (Penciclovir)
Topical antiviral cream for the treatment of cold sores (herpes labialis)
Quick Facts About Vectatone
Key Takeaways About Vectatone
- Start treatment early: Apply Vectatone at the first sign of tingling or itching on the lip for maximum effectiveness – it still works if applied at the blister stage
- Apply every 2 hours: Use during waking hours for 4 days, washing hands before and after each application
- For lips and mouth area only: Do not use near the eyes, on genitals, or on mucous membranes (inside the mouth or nose)
- Suitable for ages 12+: Not recommended for children under 12 years of age
- Shortens healing time: Penciclovir reduces healing time, pain duration, and viral shedding by up to one day compared to no treatment
What Is Vectatone and What Is It Used For?
Vectatone is a topical antiviral cream containing penciclovir 1% that treats cold sores (herpes labialis) caused by herpes simplex virus (HSV). It inhibits viral replication and can shorten healing time, pain, and detectable virus by up to one day when applied early.
Vectatone belongs to a class of medicines known as nucleoside antiviral agents. The active ingredient, penciclovir, works by interfering with the herpes simplex virus's ability to copy its DNA, thereby slowing the spread of the infection within the skin cells at the site of the cold sore. Unlike oral antiviral medications, Vectatone is applied directly to the affected area on or around the lips, providing targeted treatment exactly where it is needed.
Cold sores are a very common condition affecting an estimated 67% of the global population under the age of 50 who carry HSV-1, according to the World Health Organization. Most people experience recurrent outbreaks triggered by stress, fatigue, sun exposure, hormonal changes, or a weakened immune system. While cold sores are typically self-limiting and resolve within 7 to 10 days without treatment, antiviral creams like Vectatone can meaningfully reduce the duration and severity of an outbreak.
The cream appears as a soft, beige to light brown preparation and is available in 2 g and 5 g tubes. It is sold over-the-counter in most countries under the brand names Vectatone and Vectavir, meaning you do not need a prescription to purchase it. However, you should consult a healthcare provider if your symptoms worsen or do not improve within 4 days of starting treatment.
How does penciclovir work?
Penciclovir is a nucleoside analogue, meaning it mimics one of the building blocks that viruses use to replicate their genetic material. Once penciclovir enters virus-infected cells, it is converted into its active form, penciclovir triphosphate, by viral and cellular enzymes. This active form competitively inhibits the viral DNA polymerase – the enzyme responsible for copying the virus's DNA – effectively blocking viral replication.
One of penciclovir's notable pharmacological properties is its prolonged intracellular half-life. Once inside an infected cell, penciclovir triphosphate remains active for approximately 10 to 20 hours, significantly longer than aciclovir triphosphate (which lasts around 0.7 to 1 hour). This extended duration of action means that penciclovir continues to suppress viral replication between applications, contributing to its clinical effectiveness even with intermittent dosing.
It is important to understand that penciclovir does not cure herpes simplex infection. The virus remains dormant in nerve ganglia between outbreaks, and Vectatone treats only the active cold sore episode. Systemic absorption after topical application is minimal – penciclovir is not measurable in blood or urine after standard use – which contributes to the cream's favourable safety profile.
Vectatone is most effective when applied at the earliest stage of a cold sore outbreak – ideally when you first feel tingling, burning, or itching on the lip. However, clinical studies show it remains beneficial even when application begins at the papule or blister stage.
What Should You Know Before Using Vectatone?
Do not use Vectatone if you are allergic to penciclovir, famciclovir, or any of the other ingredients. Avoid applying it near the eyes, on genitals, or on mucous membranes. Consult a healthcare provider if you have a weakened immune system or are unsure about the cause of your sores.
While Vectatone is generally well tolerated and available without a prescription, there are several important considerations to be aware of before using this medication. Understanding who should and should not use the cream, as well as recognising potential precautions, helps ensure safe and effective treatment.
Contraindications
You should not use Vectatone if:
- You are allergic to penciclovir or any of the other ingredients in the cream (including cetostearyl alcohol, propylene glycol, liquid paraffin, white soft paraffin, macrogol cetostearyl ether 1000, iron oxides E172, and purified water)
- You have previously shown hypersensitivity to famciclovir (the oral prodrug of penciclovir, as they share a common active metabolite)
If you have ever experienced an allergic reaction to famciclovir tablets, you should also avoid Vectatone cream, as cross-reactivity between these medications is possible. Allergic reactions may include skin rash, hives, itching, swelling, or difficulty breathing.
Warnings and Precautions
Talk to a healthcare provider or pharmacist before using Vectatone if:
- You are unsure about the cause of your lip sores – not all sores around the mouth are cold sores, and other conditions (such as impetigo, angular cheilitis, or oral cancer) require different treatment
- Your cold sore worsens or does not improve after 4 days of treatment
- You have a weakened immune system (for example, from HIV/AIDS, organ transplant, or immunosuppressive medications) – topical antivirals alone may be insufficient, and your doctor may recommend oral antiviral therapy instead
Vectatone cream must not be used:
- In or near the eyes
- On the genitals
- On mucous membranes (e.g. inside the mouth or nose)
Vectatone should only be used for sores on the lips or around the mouth. If you have genital herpes, speak to your healthcare provider about appropriate treatment options.
Pregnancy and Breastfeeding
If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, seek advice from a healthcare provider or pharmacist before using Vectatone.
Pregnancy: There is limited clinical experience with the use of penciclovir cream during pregnancy. Although systemic absorption is minimal after topical application, the potential risk to the developing foetus has not been fully established. As a precautionary measure, it is advisable to consult your doctor before use.
Breastfeeding: It is not known whether penciclovir passes into breast milk after topical application. Given the minimal systemic absorption, risk to the nursing infant is considered low. However, avoid applying the cream on or near the breast area, and wash hands thoroughly after application to prevent transferring the cream to the infant.
Excipients to be aware of
Vectatone contains two excipients that some individuals may be sensitive to:
- Cetostearyl alcohol: May cause local skin reactions such as contact dermatitis in sensitive individuals
- Propylene glycol (416 mg per gram of cream): May cause skin irritation in some people, particularly those with eczema or other pre-existing skin conditions
How Does Vectatone Interact with Other Drugs?
Vectatone (penciclovir cream) has no known clinically significant drug interactions. Because systemic absorption is negligible after topical application, it is unlikely to affect or be affected by other medications taken orally or by injection.
One of the advantages of topical penciclovir is its minimal potential for drug interactions. When applied to the skin as directed, penciclovir is absorbed in extremely small amounts – so small that it is undetectable in the blood or urine. This means the cream does not enter the systemic circulation in quantities sufficient to interact with other medications.
However, it is always good practice to inform your healthcare provider or pharmacist about all medications you are currently using, have recently used, or might use. This includes prescription medicines, over-the-counter products, herbal supplements, and other topical preparations applied to the same area.
| Drug/Category | Interaction Level | Clinical Significance | Recommendation |
|---|---|---|---|
| Other topical creams/ointments | Minor | May dilute penciclovir or create a barrier reducing absorption | Avoid applying other products to the same area simultaneously |
| Oral antivirals (aciclovir, valaciclovir) | None known | No pharmacokinetic interaction expected | Can be used concurrently if prescribed by a doctor |
| Immunosuppressants | None known | No direct interaction, but immunosuppression may reduce treatment efficacy | Consult healthcare provider; oral antivirals may be preferable |
| Cosmetics and lip products | Minor | May interfere with cream adhesion and absorption | Apply Vectatone first; wait before applying cosmetics |
If you are using multiple topical products on the lip area, apply Vectatone first and allow it to absorb for a few minutes before applying any other product. This ensures that the antiviral cream has direct contact with the affected skin and can work most effectively.
Driving and Operating Machinery
Vectatone does not affect your ability to drive or operate machinery. There are no known central nervous system effects from topical penciclovir application.
What Is the Correct Dosage of Vectatone?
Adults and children over 12 years should apply Vectatone cream to the cold sore every 2 hours during waking hours for 4 days. Always wash hands before and after application. Begin treatment as early as possible after the first symptoms appear.
Always use Vectatone exactly as described in the patient information leaflet or as directed by your healthcare provider or pharmacist. If you are unsure about anything, consult your pharmacist or doctor before starting treatment.
Adults and Children Over 12 Years
Standard Dosage
Application frequency: Every 2 hours during waking hours
Duration: 4 days
Strength: Penciclovir 1% (10 mg/g)
Route: Topical – apply directly to the cold sore and surrounding area
Treatment should begin as soon as possible after the first signs of an infection – such as itching, tingling, or a burning sensation on the lip. Some people may not notice these early prodromal symptoms, but Vectatone cream is still effective if applied at the papule or blister stage.
Step-by-step application:
- Wash your hands thoroughly before applying the cream to prevent introducing bacteria to the cold sore
- Squeeze a small amount of cream onto a clean fingertip
- Apply gently to the cold sore and the immediately surrounding skin
- Wash your hands again after application to avoid spreading the virus to other areas of the body or to other people
If an application time coincides with a meal, apply the cream after eating. This helps ensure the cream remains on the affected area rather than being removed during eating.
Set a reminder on your phone every 2 hours to ensure consistent application. The more regularly you apply the cream, the more effectively it can suppress viral replication and shorten the outbreak.
Children Under 12 Years
Vectatone cream should not be used in children under 12 years of age. There is insufficient clinical data to establish the safety and efficacy of penciclovir cream in this age group. If a child under 12 develops cold sores, consult a healthcare provider for appropriate treatment recommendations.
Elderly Patients
No dosage adjustment is required for elderly patients. The standard dosing regimen (every 2 hours during waking hours for 4 days) applies regardless of age in adults. Since systemic absorption is minimal, age-related changes in kidney or liver function do not affect the use of Vectatone.
Missed Dose
If you miss a scheduled application, apply the cream as soon as you remember and then continue with the regular 2-hourly schedule. Do not apply a double amount to compensate for a missed application. It is more effective to maintain consistent, regular applications throughout the day than to apply large amounts at once.
Overdose
It is unlikely that serious problems would occur if you apply a large amount of cream at once. Some local skin irritation at the application site may occur, but no systemic toxicity is expected.
If the cream is accidentally swallowed – for example, by a child – it is not considered harmful, though some irritation of the mouth and throat may occur. No specific treatment is necessary. If you are concerned, contact a healthcare provider or your local poison control centre for advice.
| Patient Group | Dosage | Frequency | Duration |
|---|---|---|---|
| Adults (18+ years) | Small amount to cold sore | Every 2 hours (waking hours) | 4 days |
| Adolescents (12–17 years) | Small amount to cold sore | Every 2 hours (waking hours) | 4 days |
| Children (<12 years) | Not recommended – consult healthcare provider | ||
| Elderly | Small amount to cold sore | Every 2 hours (waking hours) | 4 days |
| Pregnancy/Breastfeeding | Consult healthcare provider before use | ||
What Are the Side Effects of Vectatone?
Common side effects of Vectatone include burning sensation, pain, or numbness at the application site (affecting up to 1 in 10 users). Rarely reported effects include hypersensitivity reactions, hives, and allergic contact dermatitis. Most side effects are mild and resolve on their own.
Like all medicines, Vectatone can cause side effects, although not everybody gets them. The topical route of administration means that side effects are generally limited to the application site. Systemic (whole-body) side effects are extremely rare due to the negligible absorption of penciclovir through the skin.
The side effects reported in clinical trials and post-marketing surveillance are categorised below by frequency. It is important to note that many of these reactions are similar to the symptoms of the cold sore itself, which can make it difficult to distinguish between side effects of the medication and the natural course of the infection.
Common Side Effects
- Burning sensation at the application site
- Pain or stinging at the treated area
- Numbness or tingling at the application site
Reported (Frequency Not Known)
- Hypersensitivity reactions
- Urticaria (hives)
- Allergic contact dermatitis (rash, itching, blisters, swelling)
The burning or stinging sensation experienced at the application site is the most commonly reported side effect. This is usually mild and transient, resolving within a few minutes of application. If the sensation is severe or persists, discontinue use and consult a healthcare provider.
Allergic contact dermatitis is a delayed-type hypersensitivity reaction that may develop after repeated exposure to the cream or one of its ingredients (particularly cetostearyl alcohol or propylene glycol). If you develop a rash, widespread itching, blistering, or significant swelling beyond the cold sore area, stop using Vectatone and seek medical advice.
When to Seek Medical Attention
Stop using Vectatone and seek immediate medical attention if you experience:
- Signs of a severe allergic reaction: swelling of the face, lips, tongue, or throat; difficulty breathing; widespread rash or hives
- Worsening symptoms or no improvement after 4 days of treatment
- Spreading of the sores to new areas, particularly near the eyes
Reporting Side Effects
Reporting suspected side effects after a medicine has been authorised is important. It allows continued monitoring of the medicine's benefit-risk balance. Healthcare professionals and patients are encouraged to report any suspected adverse reactions to their national pharmacovigilance authority.
How Should You Store Vectatone?
Store Vectatone below 25°C (77°F). Do not freeze. Keep out of the sight and reach of children. Do not use after the expiry date printed on the carton. Dispose of unused medicine through a pharmacy – do not throw in household waste or flush down the drain.
Proper storage of Vectatone is essential to maintain the medication's effectiveness and safety throughout its shelf life. Like all topical creams, penciclovir can degrade if exposed to extreme temperatures or inappropriate conditions.
Storage conditions:
- Temperature: Store at or below 25°C (77°F). Avoid leaving the cream in hot environments such as a car in summer or near a radiator
- Do not freeze: Freezing can alter the cream's consistency and reduce its effectiveness
- Keep out of reach of children: Store in a safe place where children cannot access it
- Expiry date: Do not use after the expiry date stated on the carton. The expiry date refers to the last day of that month
Once opened, the tube should be used within the treatment period (4 days) for the current outbreak. For future outbreaks, the tube can be used again as long as it has not passed its expiry date and has been stored correctly. Replace the cap tightly after each use.
Disposal: Do not throw medicines in wastewater or household waste. Take unused or expired medicine to a pharmacy for proper disposal. These measures help to protect the environment.
What Does Vectatone Contain?
Vectatone contains penciclovir 10 mg/g (1%) as the active ingredient. Inactive ingredients include white soft paraffin, liquid paraffin, cetostearyl alcohol, propylene glycol, macrogol cetostearyl ether 1000, iron oxides (E172), and purified water.
Understanding the full composition of Vectatone is important, particularly if you have known sensitivities or allergies to specific excipients. Below is a detailed breakdown of the cream's ingredients and their roles in the formulation.
Active Ingredient
Penciclovir 10 mg/g (1%): The antiviral agent responsible for the therapeutic effect. Penciclovir is a synthetic nucleoside analogue with selective activity against herpes simplex virus types 1 and 2 (HSV-1 and HSV-2).
Inactive Ingredients (Excipients)
- White soft paraffin: Acts as an emollient and occlusive moisturiser, forming a protective layer over the cold sore and helping to retain moisture in the skin
- Liquid paraffin: A mineral oil that serves as a solvent and emollient, giving the cream a smooth, spreadable consistency
- Cetostearyl alcohol: An emulsifier and thickening agent that stabilises the cream formulation. Note: may cause local skin reactions (e.g. contact dermatitis) in sensitive individuals
- Propylene glycol (416 mg/g): A humectant and penetration enhancer that helps penciclovir absorb into the skin. Note: may cause skin irritation in some people
- Macrogol cetostearyl ether 1000: A non-ionic emulsifier that helps blend the oil and water components of the cream
- Iron oxides (E172): Red and yellow iron oxide pigments that give Vectatone its characteristic beige to light brown colour
- Purified water: The aqueous base of the cream formulation
If you have known sensitivity to cetostearyl alcohol or propylene glycol, discuss this with your pharmacist before purchasing Vectatone. Alternative cold sore treatments with different excipient profiles may be more suitable.
Frequently Asked Questions About Vectatone
Vectatone is a topical antiviral cream containing penciclovir 1% that is used to treat cold sores (herpes labialis) caused by herpes simplex virus. It should be applied as early as possible after the first symptoms appear, such as tingling or itching on the lip. The cream inhibits viral replication and can shorten healing time, reduce pain, and decrease the duration of viral shedding by up to one day.
Vectatone should be applied every 2 hours during waking hours for a total of 4 days. Wash your hands before and after each application. If a mealtime coincides with your scheduled application, apply the cream after eating. It may take time for the cream to take effect – continue using it for the full 4-day course even if the cold sore does not seem to improve immediately.
Vectatone is approved for use in adults and children aged 12 years and over. It should not be used in children under 12 years of age, as there is insufficient data on safety and efficacy in this younger age group. For children under 12 who develop cold sores, consult a healthcare provider for appropriate treatment alternatives.
No, although both are topical antiviral creams used for cold sores. Vectatone contains penciclovir, while Zovirax contains aciclovir. Both drugs belong to the nucleoside analogue class and work by inhibiting viral DNA polymerase. However, penciclovir has a significantly longer intracellular half-life (10–20 hours vs. approximately 1 hour for aciclovir), which means it maintains antiviral activity for longer between applications. Clinical studies show comparable overall efficacy, with some evidence suggesting penciclovir may have a slight advantage in reducing healing time when treatment is started at the blister stage.
There is limited experience with Vectatone use during pregnancy, and it is not known whether penciclovir passes into breast milk after topical application. While systemic absorption from the cream is minimal, it is advisable to consult a healthcare provider before using Vectatone if you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby.
If your cold sore does not improve within 4 days of treatment, or if it worsens, stop using the cream and consult a healthcare provider. Persistent or worsening sores may indicate a different condition, a bacterial superinfection, or the need for oral antiviral therapy. People with weakened immune systems may require more intensive treatment than topical creams alone can provide.
References and Medical Sources
This article is based on the following evidence-based medical sources:
- European Medicines Agency (EMA). Penciclovir Summary of Product Characteristics. EMA Authorised Product Information. Available at: ema.europa.eu
- Spruance SL, Rea TL, Thoming C, et al. Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial. JAMA. 1997;277(17):1374-1379. doi:10.1001/jama.1997.03540410056032
- Boon R, Goodman JJ, Martinez J, et al. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Clinical Therapeutics. 2000;22(1):76-90.
- World Health Organization (WHO). Herpes Simplex Virus Fact Sheet. Updated 2024. Available at: who.int
- British National Formulary (BNF). Penciclovir Monograph. BNF. National Institute for Health and Care Excellence. Available at: bnf.nice.org.uk
- Emmert DH. Treatment of common cutaneous herpes simplex virus infections. American Family Physician. 2000;61(6):1697-1708.
- Whitley RJ, Roizman B. Herpes simplex virus infections. The Lancet. 2001;357(9267):1513-1518. doi:10.1016/S0140-6736(00)04638-9
- British Association of Dermatologists (BAD). Patient Information Leaflet: Herpes Simplex (Cold Sores). BAD Guidelines. Available at: bad.org.uk
About the Medical Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, which consists of licensed physicians, clinical pharmacologists, and dermatologists with expertise in antiviral therapy and herpes simplex management.
Medical Writing
Content created by qualified medical writers following international pharmacological guidelines and evidence-based medicine principles.
Medical Review
All content reviewed by the iMedic Medical Review Board – an independent panel of board-certified physicians ensuring accuracy and clinical relevance.
All medical content on iMedic is based on peer-reviewed research, international clinical guidelines, and official product information from regulatory authorities (EMA, FDA, WHO). We follow the GRADE evidence framework and maintain complete independence from pharmaceutical companies. Read our full editorial policy.